Essex Woodlands Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-457,085
Closed -$1.39M 7
2024
Q4
$1.39M Hold
457,085
0.32% 6
2024
Q3
$2.37M Hold
457,085
0.68% 5
2024
Q2
$1.17M Hold
457,085
0.38% 6
2024
Q1
$2.25M Hold
457,085
0.65% 5
2023
Q4
$4.02M Hold
457,085
0.99% 5
2023
Q3
$5.24M Hold
457,085
4.62% 4
2023
Q2
$11.6M Hold
457,085
8.76% 4
2023
Q1
$14.7M Hold
457,085
8.52% 3
2022
Q4
$8.44M Hold
457,085
4.7% 6
2022
Q3
$12.3M Hold
457,085
5.1% 5
2022
Q2
$6.32M Hold
457,085
2.61% 6
2022
Q1
$8.91M Hold
457,085
2.15% 6
2021
Q4
$7.46M Sell
457,085
-15,505
-3% -$253K 1.68% 7
2021
Q3
$13.2M Sell
472,590
-861,102
-65% -$24M 2.92% 7
2021
Q2
$37.3M Sell
1,333,692
-1,426,258
-52% -$39.9M 5.51% 5
2021
Q1
$77.1M Sell
2,759,950
-582,097
-17% -$16.3M 12.06% 3
2020
Q4
$94.7M Hold
3,342,047
24.58% 2
2020
Q3
$84M Hold
3,342,047
44.64% 1
2020
Q2
$81.6M Hold
3,342,047
40.04% 1
2020
Q1
$49.5M Hold
3,342,047
31.84% 1
2019
Q4
$54.2M Hold
3,342,047
25.3% 2
2019
Q3
$43.4M Hold
3,342,047
27.06% 2
2019
Q2
$43.3M Hold
3,342,047
24.99% 3
2019
Q1
$52.7M Hold
3,342,047
26.22% 3
2018
Q4
$91.7M Hold
3,342,047
36.54% 1
2018
Q3
$83.1M Hold
3,342,047
17.27% 4
2018
Q2
$91.7M Sell
3,342,047
-500,000
-13% -$13.7M 21.3% 2
2018
Q1
$118M Hold
3,842,047
25.9% 2
2017
Q4
$137M Sell
3,842,047
-750,000
-16% -$26.8M 24.83% 1
2017
Q3
$127M Hold
4,592,047
22.44% 2
2017
Q2
$121M Hold
4,592,047
21.92% 2
2017
Q1
$95.5M Hold
4,592,047
21.79% 2
2016
Q4
$95.1M Hold
4,592,047
21.68% 2
2016
Q3
$74.4M Hold
4,592,047
15.49% 3
2016
Q2
$62.5M Hold
4,592,047
15.74% 3
2016
Q1
$80.2M Hold
4,592,047
20.98% 2
2015
Q4
$157M Hold
4,592,047
28.69% 2
2015
Q3
$137M Hold
4,592,047
24.98% 2
2015
Q2
$147M Hold
4,592,047
26.51% 1
2015
Q1
$95.2M Hold
4,592,047
18.88% 2
2014
Q4
$77.8M Hold
4,592,047
24.28% 2
2014
Q3
$88.8M Hold
4,592,047
32.32% 1
2014
Q2
$156M Hold
4,592,047
32.47% 1
2014
Q1
$145M Buy
+4,592,047
New +$145M 36.82% 1